CAS 21411-53-0

Virginiamicina M1

Descrizione:

Virginiamicina M1 è un antibiotico macrolide derivato dalla fermentazione del batterio *Streptomyces virginiae*. Viene utilizzato principalmente in medicina veterinaria come promotore della crescita e per trattare alcune infezioni batteriche nel bestiame. Il composto presenta un ampio spettro di attività antimicrobica, in particolare contro i batteri Gram-positivi, ed è spesso usato in combinazione con altri antibiotici per migliorare l'efficacia e ridurre lo sviluppo di resistenza. Virginiamicina M1 agisce inibendo la sintesi proteica nei batteri, impedendo così la loro crescita e riproduzione. È noto per la sua tossicità relativamente bassa negli animali quando usato alle dosi raccomandate. Inoltre, è stato studiato per i suoi potenziali effetti sulla salute umana, in particolare riguardo alla resistenza agli antibiotici. La sostanza viene tipicamente somministrata tramite mangime o acqua in contesti agricoli. Come per molti antibiotici, una gestione attenta è essenziale per mitigare il rischio di resistenza e garantire la sostenibilità del suo uso nell'allevamento.

Formula: C₂₈H₃₅N₃O₇

InChI: InChI=1/C28H35N3O7/c1-17(2)26-19(4)9-10-24(34)29-11-5-7-18(3)13-20(32)14-21(33)15-25-30-22(16-37-25)27(35)31-12-6-8-23(31)28(36)38-26/h5,7-10,13,16-17,19-20,26,32H,6,11-12,14-15H2,1-4H3,(H,29,34)/b7-5+,10-9+,18-13+/t19-,20-,26-/m1/s1

InChI key: InChIKey=DAIKHDNSXMZDCU-FQTGFAPKSA-N

SMILES: O=C1N2C(C(=O)O[C@H]([C@@H](C)C)[C@H](C)/C=C/C(=O)NC\C=C\C(\C)=C\[C@@H](O)CC(=O)CC3=NC1=CO3)=CCC2

Sinonimi:

• (3R,4R,5E,10E,12E,14S)-14-hydroxy-4,12-dimethyl-3-(propan-2-yl)-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
• (3R,4R,5E,10E,12E,14S)-8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
• (3R,4R,5E,14S)-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
• (3R,4R,5Z,10Z,12Z,14S)-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
• (3S,4S,5Z,10Z,12Z,14R)-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
• 14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
• 3H-21,18-Nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, 8,9,14,15,24,25-hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-, (3R,4R,5E,10E,12E,14S)-
• 8,9,14,15,24,25-Hexahydro-14-hydroxy-3-isopropyl-4,12-dimethyl-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
• 8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
• Antibiotic PA 114A
• Antibiotic PA 114A1
• Factor M
• Factor M (antibiotic)
• Mikamycin A
• Nsc 244426
• Nsc 87432
• Ostreogrycin a
• Pa 114A
• Pristinamycin II
• Pristinamycin II_A
• Rp 12536
• Staphylomycin M₁
• Streptogramin A
• Vernamycin A
• Virginiamycin M₁
• Virginiamycin factor M1
• [3R-(3R*,4R*,5E,10E,12E,14S*)]-8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
• Virginiamycin M1
• VirginiaMycin M1 (90%)
• Verginiamycin M1 Ostreogrycin A Antibiotic PA 114A NSC 244426 NSC 87432
• MikamycinA, Staphylomycin
• AVirginiaMyci
• DISCONTINUED
• STAPHYLOMYCIN
• Pristinamycin IIA
• VIRGINIAMYCINE
• Virginiamycin M1, 98%, from Streptomyces virginiae
• (3R,4R,5E,10E,12E,14S)-
• C11299
• MikaMycin A, PristinaMycin IIA, StephyloMycin M1, StreptograMin A, Syncothrecin A, Synergistin A1, VirginiaMycin M1, VernaMycin A, 14752-2, E129A, PA 114A, 1745Z3A, 547C, Factor M
• Staphylomycin M1

Virginiamycin M1

CAS: 21411-53-0

Virginiamycin M1

Purezza: ≥98%

Peso molecolare: 525.59g/mol

Ref: 54-BUP08780

Virginiamycin M1 (Pristinamycin IIA)

CAS: 21411-53-0

Formula: C₂₈H₃₅N₃O₇

Colore e forma: Off-White Solid

Peso molecolare: 525.61

Ref: 4Z-V-171

Virginiamycin M1

CAS: 21411-53-0

Virginiamycin M1

Formula: C₂₈H₃₅N₃O₇

Purezza: By hplc: 98.25% (Typical Value in Batch COA)

Colore e forma: slightly yellow powder

Peso molecolare: 525.59g/mol

Ref: 54-BIV1003

Virginiamycin M

CAS: 21411-53-0

Formula: C₂₈H₃₅N₃O₇

Purezza: ≥ 95.0%

Colore e forma: Off-white to pale yellow powder

Peso molecolare: 525.6

Ref: 7W-GA3764

Virginiamycin M1

CAS: 21411-53-0

Virginiamycin M1 (Pristinamycin IIA) is a macrocyclic lactone peptide antibiotic and is a member of the streptogramin A group of antibiotics.

Formula: C₂₈H₃₅N₃O₇

Purezza: 98.57%

Colore e forma: Solid

Peso molecolare: 525.59

Ref: TM-T13303

Virginiamycin M1

Prodotto controllato

CAS: 21411-53-0

Formula: C₂₈H₃₅N₃O₇

Colore e forma: Neat

Peso molecolare: 525.59

Ref: 04-C17923500

Virginiamycin M1 (~90%) (200 ug/mL in Methanol)

Prodotto controllato

CAS: 21411-53-0

Formula: C₂₈H₃₅N₃O₇

Purezza: ~90%

Colore e forma: Single Solution

Peso molecolare: 525.59

Ref: TR-KIT0758

Virginiamycin M1 (~90%)

CAS: 21411-53-0

Applications Macrolactone antibiotic. Antibacterial; growth promotant. This compound is a contaminant of emerging concern (CECs).
References Crooy, P., et al.: J. Antibiot., 25, 371 (1972), Allington, D., et al.: Clin. Therap., 23, 24 (2001), Eeman, M., et al.: Langmuir, 22, 11337 (2006),

Formula: C₂₈H₃₅N₃O₇

Purezza: ~90%

Colore e forma: Light Yellow To Beige

Peso molecolare: 525.59

Ref: TR-V673810

Virginiamycin M1-d2

Prodotto controllato

CAS: 21411-53-0

Stability Light Sensitive
Applications Virginiamycin M1-d2 is the labelled form of Virginiamycin M1 (V673810), which is a macrolactone antibiotic, an antibacterial and growth promotant. This compound is a contaminant of emerging concern (CECs)
References Crooy, P., et al.: J. Antibiot., 25, 371 (1972), Allington, D., et al.: Clin. Therap., 23, 24 (2001), Eeman, M., et al.: Langmuir, 22, 11337 (2006),

Formula: C₂₈D₂H₃₃N₃O₇

Purezza: >90%

Colore e forma: Light Yellow

Peso molecolare: 525.59

Ref: TR-V673812

Virginiamycin M1

CAS: 21411-53-0

Inhibitor of protein synthesis; streptogramin

Formula: C₂₈H₃₅N₃O₇

Purezza: Min. 95%

Peso molecolare: 525.59 g/mol

Ref: 3D-FV159221

Virginiamycin M1

CAS: 21411-53-0

Formula: C₂₈H₃₅N₃O₇

Peso molecolare: 525.60

Ref: ST-EA-CP-V51002